Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB1002619C

beta Galactosidase Antibody (DC1 4C7), DyLight 650, Novus Biologicals™
SDP

Catalog No. NB1002619C Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB1002619C 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB1002619C Supplier Novus Biologicals Supplier No. NB1002619C
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

beta Galactosidase Monoclonal specifically detects beta Galactosidase in E. coli samples. It is validated for ELISA, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Western Blot.

Specifications

Antigen beta Galactosidase
Applications ELISA, Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Western Blot
Classification Monoclonal
Clone DC1 4C7
Conjugate DyLight 650
Dilution Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
Formulation 50mM Sodium Borate with 0.05% Sodium Azide
Gene Alias EC 3.2.1.23; b-gal
Host Species Mouse
Immunogen Beta-galactosidase EC.3.2.1.23 from E.coli
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Primary or Secondary Primary
Target Species E. coli
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.